Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity (2012)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.1016/j.clcc.2011.10.004
- Subjects: NEOPLASIAS COLORRETAIS (TERAPIA); DROGATERAPIA (TOXIDADE); METÁSTASE NEOPLÁSICA; ANTINEOPLÁSICOS (TOXIDADE); MANIFESTAÇÕES NEUROLÓGICAS; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical Colorectal Cancer
- ISSN: 1533-0028
- Volume/Número/Paginação/Ano: v. 11, n. 2, p. 93-100, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
HOFF, Paulo M. et al. Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity. Clinical Colorectal Cancer, v. 11, n. 2, p. 93-100, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.clcc.2011.10.004. Acesso em: 04 mar. 2026. -
APA
Hoff, P. M., Saad, E. D., Costa, F., Coutinho, A. K., Caponero, R., Prolla, G., & Gansl, R. C. (2012). Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity. Clinical Colorectal Cancer, 11( 2), 93-100. doi:10.1016/j.clcc.2011.10.004 -
NLM
Hoff PM, Saad ED, Costa F, Coutinho AK, Caponero R, Prolla G, Gansl RC. Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity [Internet]. Clinical Colorectal Cancer. 2012 ; 11( 2): 93-100.[citado 2026 mar. 04 ] Available from: https://doi.org/10.1016/j.clcc.2011.10.004 -
Vancouver
Hoff PM, Saad ED, Costa F, Coutinho AK, Caponero R, Prolla G, Gansl RC. Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity [Internet]. Clinical Colorectal Cancer. 2012 ; 11( 2): 93-100.[citado 2026 mar. 04 ] Available from: https://doi.org/10.1016/j.clcc.2011.10.004 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre o DOI: 10.1016/j.clcc.2011.10.004 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
